天美传媒

Abstract

Goserelin acetate is a critical therapeutic agent in hormone-sensitive cancers and gynecological conditions. In early breast cancer,  it significantly improves disease-free survival and reduces relapse when combined with adjuvant endocrine therapy or neoadjuvant  chemotherapy. It offers ovarian protection for young cancer patients and is effective for endometrial ablation, myomectomy, and  endometrial polyps. Goserelin also plays a key role in prostate cancer management. These findings collectively establish goserelin  as a versatile and impactful treatment, enhancing patient outcomes across a spectrum of clinical applications with a favorable safety  profile.